Cisplatin

nuclear factor kappa B subunit 1 ; Homo sapiens







171 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
151 17586463 Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways. 2007 Aug 17 3
152 17873517 Indomethacin enhances the cytotoxicity of recombinant human lymphotoxin alpha on tumor cells by suppressing NFkappaB signaling. 2007 Sep 1
153 16424027 Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. 2006 Jan 15 1
154 16461557 Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. 2006 Feb 6
155 16475211 Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. 2006 Mar 15 4
156 16613577 The role of genistein and synthetic derivatives of isoflavone in cancer prevention and therapy. 2006 Apr 1
157 16044419 Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. 2005 Sep 7
158 16061678 Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. 2005 Aug 1 1
159 15026414 Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. 2004 May 28 8
160 15073167 Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. 2004 Jun 18 6
161 15097869 Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. 2004 May 2
162 15246562 Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line. 2004 Aug 20 4
163 12618201 Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-kappaB-suppressed pathway. 2003 Apr 1
164 12871783 The effect of adenovirus-IkappaBalpha transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin). 2003 Aug 3
165 11942326 N-acetyl-L-cysteine enhances chemotherapeutic effect on prostate cancer cells. 2002 Mar 2
166 11996883 Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NF kappa B activation. 2002 Apr 15 5
167 11679590 NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells. 2001 Dec 28 1
168 11084634 Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. 2000 Dec 2
169 11225847 IkappaB/NF-kappaB mediated cisplatin resistance in HeLa cells after low-dose gamma-irradiation is associated with altered SODD expression. 2000 Jun 3
170 10362102 Synergistic induction of ICAM-1 expression by cisplatin and 5-fluorouracil in a cancer cell line via a NF-kappaB independent pathway. 1999 Jun 2
171 9403032 Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells. 1997 Nov 19 2